Morange PE - Search Results

1

Genetics of venous thrombosis: insights from a new genome wide association study.

Germain M, Saut N, Greliche N, Dina C, Lambert JC, Perret C, Cohen W, Oudot-Mellakh T, Antoni G, Alessi MC, Zelenika D, Cambien F, Tiret L, Bertrand M, Dupuy AM, Letenneur L, Lathrop M, Emmerich J, Amouyel P, Trégouët DA, Morange PE. Germain M, et al. Among authors: morange pe. PLoS One. 2011;6(9):e25581. doi: 10.1371/journal.pone.0025581. Epub 2011 Sep 27. PLoS One. 2011. PMID: 21980494 Free PMC article.

2

Fibrinogen, obesity and insulin resistance.

Juhan-Vague I, Morange P, Renucci JF, Alessi MC. Juhan-Vague I, et al. Blood Coagul Fibrinolysis. 1999 Feb;10 Suppl 1:S25-8. Blood Coagul Fibrinolysis. 1999. PMID: 10070814 Review. No abstract available.

3

Relationship of plasminogen activator inhibitor-1 levels following thrombolytic therapy with rt-PA as compared to streptokinase and patency of infarct related coronary artery.

Paganelli F, Alessi MC, Morange P, Maixent JM, Lévy S, Vague IJ. Paganelli F, et al. Thromb Haemost. 1999 Jul;82(1):104-8. Thromb Haemost. 1999. PMID: 10456462 Clinical Trial.

4

The A -844G polymorphism in the PAI-1 gene is associated with a higher risk of venous thrombosis in factor V Leiden carriers.

Morange PE, Henry M, Tregouët D, Granel B, Aillaud MF, Alessi MC, Juhan-Vague I. Morange PE, et al. Arterioscler Thromb Vasc Biol. 2000 May;20(5):1387-91. doi: 10.1161/01.atv.20.5.1387. Arterioscler Thromb Vasc Biol. 2000. PMID: 10807758

5

Plasma TAFI antigen variations in healthy subjects.

Chetaille P, Alessi MC, Kouassi D, Morange PE, Juhan-Vague I. Chetaille P, et al. Among authors: morange pe. Thromb Haemost. 2000 Jun;83(6):902-5. Thromb Haemost. 2000. PMID: 10896246

6

Hypofibrinolysis and increased PAI-1 are linked to atherothrombosis via insulin resistance and obesity.

Juhan-Vague I, Alessi MC, Morange PE. Juhan-Vague I, et al. Among authors: morange pe. Ann Med. 2000 Dec;32 Suppl 1:78-84. Ann Med. 2000. PMID: 11209987 Review.

7

Fat cell function and fibrinolysis.

Alessi MC, Morange P, Juhan-Vague I. Alessi MC, et al. Horm Metab Res. 2000 Nov-Dec;32(11-12):504-8. doi: 10.1055/s-2007-978677. Horm Metab Res. 2000. PMID: 11246816 Review.

8

Identification of polymorphisms in the promoter and the 3' region of the TAFI gene: evidence that plasma TAFI antigen levels are strongly genetically controlled.

Henry M, Aubert H, Morange PE, Nanni I, Alessi MC, Tiret L, Juhan-Vague I. Henry M, et al. Among authors: morange pe. Blood. 2001 Apr 1;97(7):2053-8. doi: 10.1182/blood.v97.7.2053. Blood. 2001. PMID: 11264171 Free article.

9

Combined segregation-linkage analysis of plasma thrombin activatable fibrinolysis inhibitor (TAFI) antigen levels with TAFI gene polymorphisms.

Trégouet DA, Aubert H, Henry M, Morange P, Visvikis S, Juhan-Vague I, Tiret L. Trégouet DA, et al. Hum Genet. 2001 Aug;109(2):191-7. doi: 10.1007/s004390100558. Hum Genet. 2001. PMID: 11511925

10

Weak and non-independent association between plasma TAFI antigen levels and the insulin resistance syndrome.

Aubert H, Frère C, Aillaud MF, Morange PE, Juhan-Vague I, Alessi MC. Aubert H, et al. Among authors: morange pe. J Thromb Haemost. 2003 Apr;1(4):791-7. doi: 10.1046/j.1538-7836.2003.00147.x. J Thromb Haemost. 2003. PMID: 12871417 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

293 results

Search Page